SEC Form 4 · accession 0001127602-17-010158

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Thomas C Zielinski

Officer — EVP & General Counsel

Period of report

Mar 1, 2017

Accepted (ET)

Mar 3, 2017 · 4:24 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 1, 2017	F	559	$166.97	D	17,376	D
Common Stock^F2	Mar 1, 2017	A	3,744	$0.00	A	21,120	D
Common Stock	Mar 2, 2017	M	5,000	$108.35	A	26,120	D
Common Stock	Mar 2, 2017	M	6,762	$131.80	A	32,882	D
Common Stock	Mar 2, 2017	M	11,174	$146.93	A	44,056	D
Common Stock^F3	Mar 2, 2017	S	21,908	$166.27	D	22,148	D
Common Stock^F4	Mar 2, 2017	S	1,028	$166.75	D	21,120	D
Common Stock^F1	Mar 2, 2017	F	605	$165.97	D	20,515	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F5	$166.97	Mar 1, 2017	A	15,314	A	—	Mar 1, 2027	Common Stock	15,314	15,314	D
Employee Stock Option (Right to Buy)^F6	$108.35	Mar 2, 2017	M	5,000	D	—	Jun 2, 2021	Common Stock	5,000	16,191	D
Employee Stock Option (Right to Buy)^F7	$131.80	Mar 2, 2017	M	6,762	D	—	Mar 1, 2026	Common Stock	6,762	13,527	D
Employee Stock Option (Right to Buy)^F8	$146.93	Mar 2, 2017	M	11,174	D	—	Mar 2, 2025	Common Stock	11,174	5,588	D

Explanation of responses

F1PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2Represents restricted share units. Restrictions lapse as follows: 1,248 shares each on 3/1/2018, 3/1/2019 and 3/1/2020.
F3This transaction was executed in multiple trades at prices ranging from $165.74 to $166.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4This transaction was executed in multiple trades at prices ranging from $166.74 to $166.78. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.
F6The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on 12/2/14, which is the six-month anniversary of the date on which the option was granted.
F7The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.
F8The option represents a right to purchase a total of 16,762 shares, and is exercisable in six semi annual installments with two installments of 2,793 shares each and four installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.